Success Story: No RFE! We Helped a Chinese Postdoctoral Fellow Secure NIW Success Smoothly
Client’s Testimonial:
“Thank you so much for the team's help!”
On February 25th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Fellow in the Field of Immunology (Approval Notice).
General Field: Immunology
Position at the Time of Case Filing: Postdoctoral Fellow
Country of Origin: China
State of Residence at the Time of Filing: California
Approval Notice Date: February 25th, 2025
Processing Time: 15 months, 17 days
Case Summary:
We are pleased to announce the approval of an EB-2 National Interest Waiver (NIW) petition for a highly accomplished researcher in the field of immunology. The petition was filed in November 2023 and approved in February 2025 without RFE issues.
Research Focus and Proposed Endeavor: With a Ph.D. in molecular and cellular biology, the client has dedicated her career to advancing cancer research. Her proposed endeavor is to continue identifying and characterizing novel genes and pathways that influence tumor cell behavior, with the goal of improving our understanding of cancer pathogenesis and immunotherapy. Her work holds strong potential to accelerate the development of new therapeutic strategies that enhance treatment outcomes for cancer patients in the United States and beyond.
Scholarly Contributions and Impact: The client has produced a notable body of research, including 8 peer-reviewed journal articles (with 1 first-authored) and 1 patent. Her scholarly work has been cited 124 times according to Google Scholar, reflecting its impact and recognition within the scientific community. Independent researchers have drawn upon her findings to further investigations into tumor immunology, gene expression, and therapeutic development, demonstrating the broad influence of her work.
Funding and Research Support: Her research significance is further underscored by the support it has attracted from major U.S. funding agencies, including the Department of Defense (DoD), the National Institutes of Health (NIH), and the Department of Veterans Affairs (VA). These prestigious funding sources highlight both the national importance and the innovative potential of her contributions.
Recognition and Expert Support: To strengthen the petition, four recommendation letters were submitted from leading experts in the field. These recommenders emphasized the originality of her discoveries, the clinical implications of her research, and the essential role her work plays in advancing immunotherapy and cancer biology.
“Considering that cancer continues to claim the lives of more patients in the United States every year, there is an immediate and dire need to continue the support of [Client’s] immunology research.”
NIW Approval and Outlook: By combining an impressive academic record, demonstrated innovation through patent contributions, significant citations, and strong funding support, the petition clearly established that the client is well-positioned to advance her proposed endeavor. Her ongoing research in tumor immunology will directly support U.S. national interests by driving forward the development of more effective cancer treatments and improving patient outcomes.At NAILG, we are proud to have successfully represented this client and congratulate her on this achievement. We look forward to her continued contributions to immunology and cancer research.